| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Stoke Therapeutics, Inc. (STOK) has 10 insiders with recent SEC Form 4 filings, including 8 buys and 6 sells. STOK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 570.0K | $17.00M | - | |
| Dir | 283.3K | $8.45M | - | |
| Dir | 52.5K | $1.57M | - | |
| CFO | 44.3K | $1.32M | - | |
| Other | 35.7K | $1.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2020 | Nash Huw M.81 | COO &Cbo | Sale+OE | 2,107 | $27.18 | $57,263.26 | -80.8% | |
| May 22, 2020 | Liau Gene | EVP Research &Preclinical Dev | Sale+OE | 7,500 | $30.00 | $225,000.00 | -35.7% | |
| Mar 2, 2020 | Nash Huw M.81 | COO &Cbo | Sale+OE | 49,143 | $25.89 | $1,272,549.14 | -75.4% | |
| Nov 8, 2019 | Rtw Investments, LP63 | 10% Owner | Sell | 16,434 | $28.70 | $471,631.15 | -0.5% | |
| Nov 4, 2019 | Rtw Investments, LP63 | 10% Owner | Buy | 104,873 | $29.24 | $3,066,843.09 | +3.0% | |
| Nov 1, 2019 | Rtw Investments, LP63 | 10% Owner | Buy | 68,783 | $28.59 | $1,966,612.94 | +0.7% | |
| Oct 1, 2019 | Rtw Investments, LP63 | 10% Owner | Buy | 31,560 | $21.96 | $693,029.20 | +0.9% | |
| Jun 21, 2019 | Harrison Seth Loring | Director, 10% Owner | Buy | 1,388,889 | $18.00 | $25,000,002.00 | +9.0% | |
| Jun 21, 2019 | Apple Tree Partners Iv, L.P. | 10% Owner | Buy | 1,388,889 | $18.00 | $25,000,002.00 | +9.0% | |
| Jun 19, 2019 | Rtw Investments, LP63 | 10% Owner | Buy | 555,556 | $18.00 | $10,000,008.00 | +19.8% |